EMAIL THIS PAGE TO A FRIEND

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Foam sclerotherapy for reticular veins of the chest: a retrospective review of efficacy and safety.


PMID 25533159

Abstract

No study has evaluated the use of foam sclerotherapy in treating clinically conspicuous reticular chest veins. This retrospective study evaluates patient-rated efficacy, safety, and satisfaction after foam sclerotherapy for reticular veins of the chest. A telephone-based questionnaire was used for patient self-assessment of overall improvement, satisfaction, and adverse events. All patients had been treated with 0.25% to 0.50% sodium tetradecyl sulfate (STS) foam using room air (1:4 ratio). The mean length of follow-up was 3.7 years. Twelve of 23 patients were successfully contacted, with a total of 14 treatment sessions. Overall, patients reported scores of 2.4 ± 0.8 for overall improvement (0 = none, 1 = mild, 2 = moderate, and 3 = complete resolution) and 1.75 ± 0.6 for satisfaction with results (0 = not satisfied at all, 1 = mildly satisfied, and 2 = very satisfied), with minor treatment-related adverse events. Foam sclerotherapy with STS is effective for management of reticular veins of the chest with an excellent safety profile and high long-term patient satisfaction.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

293938
Tetradecyl sulfate sodium salt, 95%
C14H29NaO4S